Featured Research

from universities, journals, and other organizations

Molecules Designed To Interfere With DNA Upon Signal

Date:
March 26, 2003
Source:
Virginia Tech
Summary:
Medical science's arsenal against cancer includes compounds that interfere with the DNA of cancer cells. However, these medicines often damage noncancer cells as well, making chemotherapy a sickening treatment. Many scientists are trying to develop compounds that can be released upon command in the presence of disease cells. Now, Virginia Tech researchers have developed a new molecule that early results show can be signaled to bind to target DNA and stop replication.

Blacksburg, Va., March 24, 2003 -- Medical science's arsenal against cancer includes compounds that interfere with the DNA of cancer cells. However, these medicines often damage noncancer cells as well, making chemotherapy a sickening treatment. Many scientists are trying to develop compounds that can be released upon command in the presence of disease cells. Now, Virginia Tech researchers have developed a new molecule that early results show can be signaled to bind to target DNA and stop replication.

Related Articles


Karen Brewer, professor of chemistry at Virginia Tech, will present the research at the 225th national meeting of the American Chemical Society March 23-27 in New Orleans.

Brewer, whose group develops mixed-metal supramolecular complexes for a wide assortment of molecular devices, has been working for sometime on DNA binding agents and photo initiated DNA cleavage agents. At the meeting, she will talk about interactions with DNA using a complex of molecules with functions that allow it to bind to DNA and to stop replication.

"This is a new class of molecules," says Brewer. "The complex does not become toxic until it receives a light signal, at which point it cleaves the DNA so that it cannot replicate."

Results in test tubes and under the microscope with different cell lines have demonstrated that the specially constructed molecules can kill cells in the presence of light.

The researchers have applied for a patent through Virginia Tech Intellectual Properties Inc. (www.vtip.org). The technology has been licensed to Carilion Biomedical Institute of Roanoke, Va.

The poster, "Mixed-metal supramolecular complexes as photochemical molecular devices and DNA binding and photocleavage agents (Inor 357)," coauthored by Brewer, Alvin A. Holder of the University of West Indies, and R. Lee Williams, Shawn M. Swavey, and Mark Elvington, all of Virginia Tech, will be presented as part of the Coordination Chemistry session of the Division of Inorganic Chemistry from 1 to 4 p.m. on Monday, March 24, in Convention Center Hall J.


Story Source:

The above story is based on materials provided by Virginia Tech. Note: Materials may be edited for content and length.


Cite This Page:

Virginia Tech. "Molecules Designed To Interfere With DNA Upon Signal." ScienceDaily. ScienceDaily, 26 March 2003. <www.sciencedaily.com/releases/2003/03/030326074349.htm>.
Virginia Tech. (2003, March 26). Molecules Designed To Interfere With DNA Upon Signal. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2003/03/030326074349.htm
Virginia Tech. "Molecules Designed To Interfere With DNA Upon Signal." ScienceDaily. www.sciencedaily.com/releases/2003/03/030326074349.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins